Position in GSK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$23,579,301
-$9,676 QoQ
Shares Held
449,815
+5.2% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#67
of 1,033 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Derivatives in GSK
reported options exposure · as of Dec 31, 2020CallValue
$36,093
CallShares
981
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Creative Planning holds $1,825,978,859 across 16 Drug Manufacturers - General names. GSK ranks #13 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
445,706 | $534,593,191 | |
| 2 | JNJ |
Johnson & Johnson
|
1,384,963 | $351,739,052 | |
| 3 | ABBV |
AbbVie Inc.
|
1,126,243 | $283,407,788 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,354,765 | $174,087,302 | |
| 5 | AMGN |
Amgen Inc
|
258,171 | $93,488,882 | |
| 6 | NVS |
Novartis AG
|
546,659 | $85,672,398 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
414,367 | $52,351,126 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
887,032 | $51,110,783 |
All Filings in GSK
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,579,301 | 449,815 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $23,588,977 | 427,414 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $18,715,723 | 381,642 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $14,386,781 | 333,336 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $11,341,670 | 295,356 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $11,167,579 | 288,270 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $7,915,942 | 234,061 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $8,629,767 | 211,100 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $7,824,967 | 203,246 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $8,313,521 | 193,924 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $6,947,860 | 187,476 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $7,252,138 | 200,059 | Shares | Sole | 2023-11-16 | |
| 2023-06-30 | $5,874,469 | 164,828 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $6,250,445 | 175,673 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,644,713 | 160,635 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $4,588,696 | 155,919 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $8,169,881 | 191,358 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,859,729 | 113,748 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,204,234 | 120,320 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,388,894 | 117,111 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $4,211,075 | 107,823 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $4,096,746 | 117,034 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $36,093 | 1,000 | Call | Sole | 2021-01-29 | |
| 2020-12-31 | $3,652,511 | 101,196 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $3,821,274 | 103,509 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $4,160,350 | 103,991 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $3,746,724 | 100,820 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||